Hot Topics

(Image: Getty/mthipsorn)

Takeda secures Shire bid for $62.11bn

By Melissa Fassbender

Takeda has acquired Shire for approximately $62.11bn (£46bn) to create a Japan-headquartered biopharmaceutical company with a robust pipeline and expanded geographical footprint.

GettyImages: Devonyu

Lundbeck to buy Prexton in potential $1bn+ deal

By Staff Reporter

The Danish drugmaker says it will take responsibility for commercial manufacturing after acquiring Parkinson’s disease candidate foliglurax in a deal worth up to €905m ($1.1bn).